We are live on ! Find out more
Amundi

Amundi Portfolio holdings

AUM $367B
1-Year Est. Return 31.23%
 

Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.

This Fund
S&P 500
This Quarter Est. Return
-14.72%
1 Year Est. Return
+31.23%
3 Year Est. Return
+96.94%
5 Year Est. Return
+128.55%
10 Year Est. Return
AUM
$125B
AUM Growth
-$23.1B
Cap. Flow
+$373M
Cap. Flow %
0.3%
Top 10 Hldgs %
17.71%
Holding
1,750
New
104
Increased
631
Reduced
657
Closed
91

Top Buys

Rank Stock Value
1
FCX icon
Freeport-McMoran
FCX
+$302M
2
AMD icon
Advanced Micro Devices
AMD
+$270M
3
CAH icon
Cardinal Health
CAH
+$257M
4
ADBE icon
Adobe
ADBE
+$221M
5
V icon
Visa
V
+$218M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$257M
2
BAC icon
Bank of America
BAC
+$245M
3
SWK icon
Stanley Black & Decker
SWK
+$240M
4
KO icon
Coca-Cola
KO
+$232M
5
CSCO icon
Cisco
CSCO
+$225M

Sector Composition

Rank Sector Weight
1 Technology 22.38%
2 Healthcare 15.51%
3 Financials 12.11%
4 Consumer Discretionary 11.09%
5 Industrials 8.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XENE icon
1326
Xenon Pharmaceuticals
XENE
$6.32B
$115K ﹤0.01%
3,581
-745
-17% -$22.5K
NGM
1327
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$115K ﹤0.01%
+7,407
New +$103K
ARQT icon
1328
Arcutis Biotherapeutics
ARQT
$3.42B
$114K ﹤0.01%
+4,774
New +$97.9K
INSM icon
1329
Insmed
INSM
$23.2B
$114K ﹤0.01%
4,918
LFST icon
1330
Lifestance Health
LFST
$4.16B
$112K ﹤0.01%
20,127
+4,415
+28% +$33.8K
TWST icon
1331
Twist Bioscience
TWST
$5.62B
$112K ﹤0.01%
2,720
-101
-4% -$3.58K
CHEF icon
1332
Chefs' Warehouse
CHEF
$3.87B
$111K ﹤0.01%
3,041
-640
-17% -$22.5K
SPT icon
1333
Sprout Social
SPT
$455M
$110K ﹤0.01%
2,013
VIR icon
1334
Vir Biotechnology
VIR
$1.47B
$110K ﹤0.01%
3,842
ONEM
1335
DELISTED
1Life Healthcare
ONEM
$110K ﹤0.01%
11,579
-267
-2% -$2.29K
IHI icon
1336
iShares US Medical Devices ETF
IHI
$3.02B
$109K ﹤0.01%
2,190
TIGO icon
1337
Millicom
TIGO
$15.8B
$108K ﹤0.01%
8,296
+3,416
+70% +$70.1K
ENVX icon
1338
Enovix
ENVX
$862M
$106K ﹤0.01%
+12,602
New +$119K
CLNE icon
1339
Clean Energy Fuels
CLNE
$447M
$104K ﹤0.01%
20,899
+5,843
+39% +$33.8K
MMSI icon
1340
Merit Medical Systems
MMSI
$4.43B
$103K ﹤0.01%
+1,985
New +$121K
TSP
1341
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$103K ﹤0.01%
+12,051
New +$110K
BPMC
1342
DELISTED
Blueprint Medicines
BPMC
$102K ﹤0.01%
1,948
DNLI icon
1343
Denali Therapeutics
DNLI
$3.67B
$102K ﹤0.01%
3,017
ISEE
1344
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$102K ﹤0.01%
+8,913
New +$112K
RXDX
1345
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$100K ﹤0.01%
+3,460
New +$100K
MEOH icon
1346
Methanex
MEOH
$4.32B
$99K ﹤0.01%
2,898
SSYS icon
1347
Stratasys
SSYS
$697M
$99K ﹤0.01%
5,528
-251
-4% -$4.94K
ADPT icon
1348
Adaptive Biotechnologies
ADPT
$3.56B
$97K ﹤0.01%
+10,106
New +$88.9K
AGNT
1349
AGNT Inc
AGNT
$664M
$97K ﹤0.01%
7,349
-439
-6% -$6.35K
NEO icon
1350
NeoGenomics
NEO
$1.81B
$97K ﹤0.01%
+11,685
New +$112K

Similar funds

Amundi's Q2 2022 Portfolio in Review

As of Q2 2022, Amundi held 1,750 positions worth $125B, down 16% from $148B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Amundi's Q2 2022 filing shows 104 new, 631 increased, 657 reduced and 91 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 188,190 shares worth $71.5M. The largest sale was Procter & Gamble, an estimated $257M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Amundi's largest Q2 2022 buy was iShares Core S&P 500 ETF: 188,190 shares worth $71.5M.
  • Amundi added most to Freeport-McMoran in Q2 2022, an estimated $302M increase.
  • Amundi's biggest Q2 2022 reduction was Procter & Gamble, cutting an estimated $257M.
  • Amundi fully exited Cerner Corp in Q2 2022, selling an estimated $152M.
  • Amundi's ten largest holdings make up 18% of its $125B portfolio in Q2 2022.
  • Amundi opened 104 new positions and closed 91 in Q2 2022.
  • Amundi's portfolio value fell 16% quarter-over-quarter to $125B.

Based on Amundi's 13F filing for Q2 2022, filed 15 Aug 2022.